Company news

Geron Corporation news in 2026

Geron Corporation's news releases, calls and decks from 2026, newest first.

View company

Geron Corporation to Present Data Highlighting Clinical and Biological Activity of RYTELO® (imetelstat) at ASH 2026

November 4, 2026

Geron Corporation Reports Third Quarter 2026 Financial Results and Recent Business Highlights

November 4, 2026

Geron Corporation to Participate in the Stifel 2026 Healthcare Conference

November 3, 2026

Geron Corporation Provides Update on Phase 3 IMpactMF Clinical Trial of Imetelstat in Relapsed/Refractory Myelofibrosis

October 28, 2026

Geron Plans to Announce Third Quarter 2026 Financial Results on November 4, 2026

October 21, 2026

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

October 19, 2026

Geron Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Geron Corporation - GERN

October 12, 2026

Geron Corporation Announces Oral Presentations Highlighting Imetelstat at International Hematology Congresses in Europe and Asia

October 12, 2026

Geron Corporation Reports Second Quarter 2026 Financial Results and Recent Business Highlights

August 5, 2026

Geron Plans to Announce Second Quarter 2026 Financial Results on August 5, 2026

July 22, 2026

Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - July 14, 2026

July 15, 2026

Geron Announces Appointment of Chinmaya Rath as Chief Business Officer

July 13, 2026

Geron Corporation Reports Inducement Grants under Nasdaq Listing Rule 5635(4)

June 19, 2026

Geron to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference

June 1, 2026

First Real-World Evidence Study of RYTELO® (imetelstat) in Lower-risk Myelodysplastic Syndromes (LR-MDS) to be Presented at EHA 2026

May 12, 2026

Geron Corporation Reports First Quarter 2026 Financial Results and Recent Business Highlights

May 6, 2026

Geron Plans to Announce First Quarter 2026 Financial Results on May 6, 2026

April 22, 2026

Geron Announces Appointment of Timothy Williams as Executive Vice President, Chief Legal Officer and Corporate Secretary

April 12, 2026

Geron to Participate in the 25th Annual Needham Virtual Healthcare Conference

April 5, 2026

Geron Announces Appointment of New Members to its Board of Directors

March 25, 2026

Geron Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

February 24, 2026

Geron Plans to Present at Upcoming Investor Conferences

February 22, 2026

Geron Plans to Announce Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026

February 11, 2026

Geron Corporation Provides 2026 Financial Guidance

January 11, 2026

Calls in 2026

Decks in 2026